These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 20950884

  • 21. Obesity as a protective factor for postmenopausal osteoporosis.
    Albala C, Yáñez M, Devoto E, Sostin C, Zeballos L, Santos JL.
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1027-32. PubMed ID: 8923160
    [Abstract] [Full Text] [Related]

  • 22. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN, Hammami MM, Bakheet SM, Khan BA.
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [Abstract] [Full Text] [Related]

  • 23. Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India.
    Khinda R, Valecha S, Kumar N, Walia JPS, Singh K, Sethi S, Singh A, Singh M, Singh P, Mastana S.
    Int J Environ Res Public Health; 2022 Mar 04; 19(5):. PubMed ID: 35270692
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M.
    Saudi Med J; 2004 Oct 04; 25(10):1423-7. PubMed ID: 15494815
    [Abstract] [Full Text] [Related]

  • 25. Retinol-binding protein 4 is positively associated with bone mineral density in patients with type 2 diabetes and osteopenia or osteoporosis.
    Huang N, Zhou J, Wang W, Wang Q, Tang Y, Sun Y, Wang D, Chen S.
    Clin Endocrinol (Oxf); 2018 May 04; 88(5):659-664. PubMed ID: 29394455
    [Abstract] [Full Text] [Related]

  • 26. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.
    Xu Y, Shen L, Liu L, Zhang Z, Hu W.
    Front Endocrinol (Lausanne); 2022 May 04; 13():843912. PubMed ID: 35898467
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
    Alcalde Vargas A, Pascasio Acevedo JM, Gutiérrez Domingo I, García Jiménez R, Sousa Martín JM, Ferrer Ríos MT, Sayago Mota M, Giráldez Gallego A, Gómez Bravo MA.
    Transplant Proc; 2012 May 04; 44(6):1496-8. PubMed ID: 22841194
    [Abstract] [Full Text] [Related]

  • 29. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.
    Menopause; 2013 Jan 04; 20(1):72-8. PubMed ID: 22968256
    [Abstract] [Full Text] [Related]

  • 30. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun 04; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of Osteoporosis in Women in Buenos Aires Based on Bone Mineral Density at the Lumbar Spine and Femur.
    Mautalen C, Schianchi A, Sigal D, Gianetti G, Vidan V, Bagur A, González D, Mastaglia S, Oliveri B.
    J Clin Densitom; 2016 Oct 04; 19(4):471-476. PubMed ID: 26948141
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the relationship between homocysteine levels and bone mineral density in postmenopausal women.
    Garcia-Alfaro P, Rodriguez I, Pascual MA.
    Climacteric; 2022 Apr 04; 25(2):179-185. PubMed ID: 33982610
    [Abstract] [Full Text] [Related]

  • 33. Systemic immune-inflammation index and bone mineral density in postmenopausal women: A cross-sectional study of the national health and nutrition examination survey (NHANES) 2007-2018.
    Tang Y, Peng B, Liu J, Liu Z, Xia Y, Geng B.
    Front Immunol; 2022 Apr 04; 13():975400. PubMed ID: 36159805
    [Abstract] [Full Text] [Related]

  • 34. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
    Zhou YJ, Li A, Song YL, Zhou H, Li Y, Tang YS.
    Chin Med Sci J; 2013 Sep 04; 28(3):135-9. PubMed ID: 24074614
    [Abstract] [Full Text] [Related]

  • 35. Prevalence of low central bone mineral density in a Bulgarian female referral population: a pilot study.
    Boyanov MA.
    Rheumatol Int; 2006 Apr 04; 26(6):523-9. PubMed ID: 16082556
    [Abstract] [Full Text] [Related]

  • 36. Prevalence and risk factors of osteopenia and osteoporosis among postmenopausal women: A cross-sectional study from Jordan.
    Khurmah MHA, Alkhatatbeh MJ, Alshogran OY, Alarda HM.
    Public Health Nurs; 2024 Apr 04; 41(5):996-1005. PubMed ID: 39037197
    [Abstract] [Full Text] [Related]

  • 37. Positive association between serum uric acid and bone mineral density in Chinese type 2 diabetes mellitus stratified by gender and BMI.
    Xu M, Su J, Hao J, Zhong N, Zhang Z, Cui R, Li F, Sheng C, Zhang G, Sheng H, Qu S.
    J Bone Miner Metab; 2018 Sep 04; 36(5):609-619. PubMed ID: 29124433
    [Abstract] [Full Text] [Related]

  • 38. Associations between body morphology and bone mineral density in premenopausal women.
    Orozco P, Nolla JM.
    Eur J Epidemiol; 1997 Dec 04; 13(8):919-24. PubMed ID: 9476822
    [Abstract] [Full Text] [Related]

  • 39. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
    Halper-Stromberg E, Gallo T, Champakanath A, Taki I, Rewers M, Snell-Bergeon J, Frohnert BI, Shah VN.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):746-53. PubMed ID: 31676897
    [Abstract] [Full Text] [Related]

  • 40. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF, Passadakis SP, Tam P, Memmos ED, Katopodis PK, Ozener C, Akçiçek F, Camsari T, Ateş K, Ataman R, Vlachojannis JG, Dombros AN, Utaş C, Akpolat T, Bozfakioğlu S, Wu G, Karayaylali I, Arinsoy T, Stathakis PC, Yavuz M, Tsakiris JD, Dimitriades CA, Yilmaz ME, Gültekin M, Karayalçin B, Yardimsever M, Oreopoulos DG.
    J Bone Miner Metab; 2006 Mar 01; 24(1):79-86. PubMed ID: 16369903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.